期刊文献+

宫颈癌组织中转录因子Skn-1 a cDNA的克隆及表达

cDNA cloning and expressing of human Skn-1a cDNA from cervical carcinoma tissue
下载PDF
导出
摘要 目的:从宫颈癌组织中扩增与上皮细胞分化和人乳头瘤病毒(HPV)基因表达相关的转录因子Skn-1acDNA,进而在真核细胞中表达该转录因子以了解其功能。方法:从宫颈癌组织中提取总RNA,以此为模板,RT-PCR扩增Skn-1acDNA片段,将该cDNA片段克隆至pMD18-T载体并进行序列分析,构建Skn-1a真核表达载体,并转染Hela细胞,检测其表达情况。结果:RT-PCR扩增得到约1 300 bp的cDNA片段,将其克隆至pMD18-T载体,DNA测序表明,得到片段长度为1 308 bp,为转录因子Skn-1a基因编码的cDNA,获得的Skn-1acDNA序列与已公布的Skn-1acDNA序列具有99.85%同源性,有1个碱基的差异,但并未导致编码氨基酸的改变,继而构建了Skn-1a真核表达载体pcDNA3/Skn-1a,其转染Hela细胞后可正确表达。结论:转录因子Skn-1a在宫颈癌组织中有一定量的表达,并在体外培养的Hela细胞中获得表达。 Objective: To clone cDNA of human transcription factor .Skn-1a (related to epidermal differentiation and HPV gene expression) gene from cervical carcinoma tissue and construct the eukaryotic expression vector of the Skn-1a cDNA. Methods: The Skn-1a cDNA fragment was amplified by RT-PCR from total RNA that was extracted from cervical carcinoma tissue,the PCR product was cloned into pMD18-T vector and the nucleotide sequence was analyzed, subsequently, the eukaryotic expression vector of the Skn-1a cDNA was constructed, and transfected Hela cells, the expression of Skn -1a was examined. Results: A cDNA fragment about 1300 bp was amplified by RT-PCR,the result of sequencing showed the fragment was 1 308 bp in length, containing a cDNA coding human Skn-1a . The nuclcotide sequence homology to the previously published sequence of human .Skn-1a was 99.85%, there was one conversion in nucleic acid sequences, but the conversion didn't induce the change of coding amino acid; the eukaryotic expression vector of Skn-1a can express correctly after transfecting Hela cells. Conclusions: The results suggested that Skn- 1a gene expresses at some level in the cervical carcinoma tissue, and Skn-1a cDNA can express in vitro culture Hela cells. The research provide basis for further exploring the relationship between Skn-1a and cervical carcinoma.
出处 《新疆医科大学学报》 CAS 2006年第5期397-400,共4页 Journal of Xinjiang Medical University
基金 教育部科学技术研究重点项目(02171) 新疆维吾尔自治区自然科学基金项目(200221103)
关键词 宫颈癌 Skn-1a 克隆 表达 cervical carcinoma Skn- 1 a cloning expression
  • 相关文献

参考文献17

  • 1Andersen B,Rosenfeld MG.POU domain factors in the neuroendocrine system:lessons from developmental biology provide insights into human disease[J].Endocr Rev,2001,22(1):2-35.
  • 2Ndisang D,Budhram-Mahadeo V,Singer A,et al.Widespread elevated expression of the human papilloma virus (HPV)-activating cellular transcription factor Brn-3a in the cervix of women with CIN3 (cervical intraepithelial neoplasia stage 3)[J].Clin Sci (Lond),2000,98(5):601-602.
  • 3Cabral A,Fischer DF,Vermeij WP,et al.Distinct functional interactions of human Skn-1 isoforms with Ese-1 during keratinocyte terminal differentiation[J].J Biol Chem,2003,278(20):17792-17799.
  • 4Hildesheim J,Foster RA,Chamberlin ME,et al.Characterization of the regulatory domains of the human Skn-1a/Epoc-1/Oct-11 POU transcription factor[J].J Biol Chem,1999,274(37):26399-26406.
  • 5Enomoto K,Enomoto Y,Ishii Y,et al.Genes up-or down-regulated by expression of keratinocyte-specific POU transcription factor hSkn-1a[J].Biochem Biophys Res Commun,2003,303(2):580-585.
  • 6Hildesheim J,Kuhn U,Yee CL,et al,Yancey KB,Vogel JC.The hSkn-1a POU transcription factor enhances epidermal stratification by promoting keratinocyte proliferation[J].J Cell Sci,2001,114(10):1913-1923.
  • 7李庭芳,古力娜.库尔班,古丽沙热,贺国丽,王涛,海日古丽,王振华.新疆伽师县夏普桃勒乡妇女子宫颈癌防治研究[J].新疆医学院学报,1996,19(3):199-203. 被引量:64
  • 8马正海,张富春,梅新娣,马彩玲,刘开江.新疆南部地区维吾尔族妇女宫颈癌组织中人乳头状瘤病毒16型L1基因突变谱分析[J].中华医学杂志,2004,84(12):987-991. 被引量:18
  • 9马正海,张富春,梅新娣,马彩玲,刘开江.新疆维吾尔族妇女宫颈癌组织中HPV16型E6基因突变分析[J].癌症,2004,23(9):1016-1020. 被引量:17
  • 10Hwang TS,Jeong JK,Park M,et al.Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray[J].Gynecol Oncol,2003,90(1):51-56..

二级参考文献30

  • 1薛月珍.癌基因与宫颈癌发病的关系[J].国外医学(妇产科学分册),1994,21(4):196-198. 被引量:2
  • 2陆克昭,朱明,秦飞,杨允娇,徐英,李庭芳,王月珠,贾文阁,林玉纯.新疆宫颈癌与人乳头瘤病毒(HPV)感染关系的初步研究[J].新疆医学院学报,1989,12(3):153-156. 被引量:2
  • 3李庭芳,古力娜.库尔班,古丽沙热,贺国丽,王涛,海日古丽,王振华.新疆伽师县夏普桃勒乡妇女子宫颈癌防治研究[J].新疆医学院学报,1996,19(3):199-203. 被引量:64
  • 4Matsumoto K, Yoshikawa H, Nakagawa S, et al. Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population [J]. Cancer Lett,2000,156:159- 165.
  • 5Londesborough P, Ho L, Terry G, et al. Human papillomavirus genotype as a predictor of persistence and development of high grade lesions in women with minor cervical abnormalities [J]. Int J Cancer, 1996, 69:364- 368.
  • 6Zehbe I, Wilander E, Delius H, et al. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype [J]. Cancer Res, 1998, 58:829- 833.
  • 7Zehbe I, Voglino G, Wilander E, et al. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development [J]. Cancer Res, 2001, 61:608- 611.
  • 8Zehbe I, Voglino G, Delius H, et al. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms [J]. Lancet, 1998, 352:1441- 1442.
  • 9Zehbe I, Tachezy R, Mytilineos J. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes [J]. Int J Cancer, 2001, 94:711- 716.
  • 10Matsumoto K, Yasugi, Nakagawa S. Human papillomavirus 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer [J]. Int J Cancer, 2003, 106:919- 922.

共引文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部